In their debut trading on Friday, October 9 Spruce Biosciences, Inc. showed a 13.33% raise and closed at $17 per share. Shortly before the company placed its shares in an IPO priced $15 per share.
Заполните форму и наш специалист свяжется с вами в ближайшее время для уточнения деталей